PPIST03328
Protein Information
| Protein_Chain | A |
|---|---|
| Protein_Sequence | IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT |
Peptide Information
| Peptide_Chain | B |
|---|---|
| Peptide_Sequence | LCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE |
| Peptide_Length | 51 |
| Non-standard residues | No |
Interaction Information
| PDB_ID | 2PHB |
|---|---|
| Method | X-RAY DIFFRACTION |
| Resolution | 2.30 angstrom |
| Structure | |
| Protein-peptide residue interaction | |
| Interaction_xlsx | Download interaction table (.xlsx) |
Reference Information
| Title | The discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an orally efficacious factor Xa inhibitor |
|---|---|
| Release_Year | 2007 |
| PMID | 17683371 |
| DOI | 10.1111/j.1747-0285.2007.00539.x |